Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/ijir201353.pdf
Reference38 articles.
1. National Institutes of Health. NIH consensus development panel on impotence. Impotence. JAMA 1993; 270: 83–90.
2. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004; 1: 6–23.
3. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J et al. EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006; 49: 806–815.
4. Moncada I, Martínez-Jabaloyas JM, Rodriguez-Vela L, Gutiérrez PR, Giuliano F, Koskimaki J et al. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial. J Sex Med 2009; 6: 3469–3477.
5. Althof SE, Berner MM, Goldstein I, Claes HI, Cappelleri JC, Bushmakin AG et al. Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med 2010; 7: 3170–3178.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PDE5is‐naïve versus non‐naïve patients at first investigation for erectile dysfunction—findings from a long‐term, real‐life cross‐sectional study;Andrology;2024-04-08
2. Intracellular cGMP increase is not involved in thyroid cancer cell death;PLOS ONE;2023-03-30
3. Men’s Feminist Identification and Reported Use of Prescription Erectile Dysfunction Medication;The Journal of Sex Research;2022-02-01
4. Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction;International Journal of Clinical Pharmacy;2020-11-12
5. Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, Pulmonary Hypertension, and Lower Urinary Tract Symptoms;The Journal of Sexual Medicine;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3